5 - Contents

6-7 NEWS
Sobi to acquire CTI BioPharma for $1.7bn; Eli Lilly’s Alzheimer’s drug slows disease

8-9 NEWS
AbbVie’s Rinvoq approved by FDA; WHO report shows gaps in AMR antibiotic pipeline

10-11 DERMATOLOGY NEWS
BMS’s Sotyktu approved by MHRA; Incyte’s Opzelura cream receives EC approval

12 DARWIN'S MEDICINE
It is better to understand commercial caution than to criticise it

13 POLICY AND PUBLIC HEALTH
What will our epitaph read? We came,
we saw – we did nothing

14 RETURN ON INVESTMENT
If we are being asked to demonstrate ROI, we first need to agree on the value of the outcome

15 INNOVATIVE IMPACT BLOG
The launch landscape

16-17 USING KNOWLEDGE GRAPHS TO DISCOVER POWERFUL NEW INSIGHTS
Whether via new standards adoption or the digital transformation of regulatory processes, data-based ambitions have featured heavily on the pharma agenda in recent years, but it could be knowledge-based graphs and their ability to draw advanced insights from complex data correlations that yield the real benefits

18-19 DRIVING CONSCIOUS INCLUSION
Inclusion and diversity make a fundamental contribution to the success of an organisation and its culture, from driving innovation and challenging conventional thinking to attracting and retaining top talent

22-23 AI – THE NEXT PARADIGM SHIFT IN HEALTHCARE
Speaking at a webinar, Bertalan Meskó shared the top trends affecting the future of the pharmaceutical and biotechnology industries and also named barriers to innovation, with practical steps executives can take to drive progress

26-28 POWERING CREATIVITY TO WORK IN HARMONY WITH SCIENCE AND DATA
Companies need creativity at the heart of their output – with social media and new channels presenting new horizons and challenges.
Social media provides new and rapid routes to HCPs and patients – a lot happens on the internet in a minute: nine million Facebook messages are sent, 20,000 people are active on LinkedIn, 575,000 tweets are posted, 174,000 Apps are downloaded and 167 million TikTok videos are viewed

30-32 CHOOSING CAPABILITIES
Why does tomorrow’s business model need to be more capable than today’s model? In his second article in the series, Brian D Smith builds on the premise of his first article, that competitiveness depends on capabilities and corporate competitiveness depends on what the firm is able to do better than its rivals

37 HEALTHCARE COMMS
The CM Group rebrands to OPEN Health; AMICULUM announces opening of latest UK office

June 2023